pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,244 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT787Endpoints593BioPharma Dive228onclive165Fierce Biotech64BioSpace63raps25
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?
    <figure><div><img src="https://imgproxy.divecdn.com/xbHcBuJpB2jn4XdBnacn9EL1qH4IPhhgp3V92WERlvI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TY3JlZW5zaG90XzIwMjYtMDYtMDNfYXRfM…
    BioPharma Dive · 1mo ago↗ source
  • Opinion: How living and practicing medicine abroad complicated my beliefs about universal health care systems
    “I believe deeply in universal health care. But universal care must also mean universal safety and accountability, not merely universal access.”
    STAT · 1mo ago↗ source
  • Tiny HHS office tasked with protecting research participants’ safety is running on fumes
    OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effectively protect volunteers.
← prev
page 25 of 50
next →
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
STAT · 1mo ago
↗ source
  • HHS confirms Americans with high-risk Ebola exposures will have access to experimental therapy
    Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental antibody treatment.
    STAT · 1mo ago↗ source
  • STAT+: Drug companies, patient groups urge FDA to pause commissioner’s voucher program
    The White House has used the program to reward companies that help its political goals.
    STAT · 1mo ago↗ source
  • What RevMed’s pancreatic cancer drug meant for one patient
    Why did a presentation on Revolution Medicines' pancreatic cancer drug get a standing ovation? Why did biotech stocks perform so badly this week? Find out on "The Readout LOUD."
    STAT · 1mo ago↗ source
  • STAT+: Otsuka kidney drug slowed loss of function, but less than expected, in late-stage trial
    Otsuka’s Voyxact slowed the loss of kidney function after one year in patients with a chronic autoimmune kidney disease, but the benefit was less than expected.
    STAT · 1mo ago↗ source
  • STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
    The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.
    STAT · 1mo ago↗ source
  • STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach
    For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might get the treatment or if there will be enough…
    STAT · 1mo ago↗ source
  • STAT+: RFK Jr.’s second year: Vacancies, not vaccines
    Assessing the health secretary's biggest challenges, and a look at new rules that inject politics into the NIH.
    STAT · 1mo ago↗ source
  • Alnylam, Inceptive ink AI deal potentially worth $2B
    <figure><div><img src="https://imgproxy.divecdn.com/P4t6bXReDt38WSAYgOURAt4xJKdAoNeWhBCpIpLUOkI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9BbG55bGFtX1Bob3RvXzEuSlBH.webp"/><…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: AI titans push Congress for DNA safeguards
    Inceptive Nucleics and Alnylam's partnership, why Grail's "failed" trial still matters, and other biotech news from The Readout
    STAT · 1mo ago↗ source
  • STAT+: Utah Medical Board scolded for going rogue with AI criticism
    In this edition of STAT Health Tech: An update on the Utah pilot that uses a chatbot to renew drug prescriptions, AI scribes for patients, and more.
    STAT · 1mo ago↗ source
  • An ADC specialist sinks on safety concerns for blood cancer drug
    <figure><div><img src="https://imgproxy.divecdn.com/WrykHCObgQORJy6_Nsx19TUHTg8V8DEoa5UN1HcFlZc/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTcxODMyMDY3LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Otsuka showcases kidney drug data; Pfizer cuts an AI deal
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
    Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting law
    STAT · 1mo ago↗ source
  • Scientists uncover a new hiding spot for HIV
    An Ebola update, Trump to strip job protections of NIH officials, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • STAT+: Does Revolution Medicines’ pancreatic cancer drug have even greater potential?
    Revolution Medicines' pancreatic cancer drug has not yet been approved — and already talk has shifted to how (and when) its use might be expanded.
    STAT · 1mo ago↗ source
  • Male puberty is understudied — but when it starts may predict long-term health risks
    Due to a significant gender gap, far less is known about the health risks of early or late puberty onset among boys than girls.
    STAT · 1mo ago↗ source
  • What happens at a longevity festival?
    What happens at a longevity festival? On this week's STATus Report, Alex Hogan gets a dispatch from STAT's Sarah Todd.
    STAT · 1mo ago↗ source
  • Opinion: Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story
    An oncologist shares three lessons from the world’s first randomized trial on a multi-cancer early detection.
    STAT · 1mo ago↗ source
  • Opinion: Lawmakers promised cancer patients would be protected from Medicaid cuts. Now CMS says otherwise
    “One of the cancer community’s worst fears is coming to pass,” writes Gwen Nichols of Blood Cancer United.
    STAT · 1mo ago↗ source
  • STAT+: After hospitals, patients get a turn to bring AI into the doctor’s office
    Ambient scribes were the first large-scale application of AI in health care. Now developers are pitching them as diligent note-takers for patients.
    STAT · 1mo ago↗ source
  • A Spanish biotech banks $87M to make differentiated ADCs
    <figure><div><img src="https://imgproxy.divecdn.com/BSrwpN_TCQ9s_G6VqustJVQZXqRe4AvLiM4K23K7XDc/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNzE1OTEyNzcxLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Trump administration to strip job protections of top NIH officials, grants staff
    Among the affected positions, which the White House estimates to be 8,000, are high-level officials who oversee research grants from the NIH.
    STAT · 1mo ago↗ source